Michael S. Glickman MD is a Member in the Immunology Program of the Sloan Kettering Institute, an Attending Physician in Infectious Diseases at Memorial Hospital, and an Alfred Sloan Chair at MSKCC, where he directs the Center for Experimental Immunooncology. A microbiologist and immunologist, Dr. Glickman’s research focuses of the pathogenesis of mycobacterial infections and the interaction of microbes with cancer cells. Dr. Glickman is a graduate of Dartmouth College and an AOA graduate of Columbia University College of Physicians and Surgeons and completed internal medicine clinical training at the Massachusetts General Hospital of Harvard Medical School. He completed Infectious Diseases clinical training at the Albert Einstein College of Medicine/Montefiore Medical Center. He was a postdoctoral fellow with Dr. William Jacobs of AECOM and HHMI. Dr. Glickman has discovered and characterized multiple pathways in both pathogen and host that mediate mycobacterial infection. He is also an expert in the mechanisms of action of BCG as a cancer therapy, in addition to the intersection of cancer cells with microbes. Dr. Glickman is an inductee of the American Society of Clinical Investigation (ASCI), the Association of American Physicians (AAP), a Fellow of IDSA, and is an elected fellow of the American Academy of Microbiology.